Neonatology

PubMed Free Full Text

Newborn respiratory tract diseases: postnatal corticosteroids

Canada

• Canadian Paediatric Society
  • Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants [2020]

Europe

• PLoS ONE
  • Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study [2017]

High-income countries

• Cochrane Database of Systematic Reviews
  • Late (>= 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants [2021]
  • Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants [2021]

• Neonatology
  • Trends, Characteristic, and Outcomes of Preterm Infants Who Received Postnatal Corticosteroid: A Cohort Study from 7 High-Income Countries [2023]

Republic of Korea

• BMJ Paediatrics Open
  • Factors associated with the response to postnatal dexamethasone use in very low birthweight infants: a nationwide cohort study [2023]

United Kingdom

• BMJ Open
  • Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study [2022]

United States

• American Academy of Pediatrics
  • Postnatal Corticosteroids to Prevent or Treat Chronic Lung Disease Following Preterm Birth [2022]
  • Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia [2014]

• Journal of Perinatology
  • The Use of Supplemental Hydrocortisone in the Management of Persistent Pulmonary Hypertension of the Newborn [2021]
  • Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia [2021]
  • Using quality improvement to implement consensus guidelines for postnatal steroid treatment of preterm infants with developing bronchopulmonary dysplasia [2020]

• National Institute of Child Health and Human Development
  • Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial [2023]
  • Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants [2023]
  • Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes [2020]

{Related topics}

• Topic
  • Newborn respiratory tract diseases